Gepirone

未知生产厂商

Gepirone is a serotonin receptor agonist used to treat major depressive disorder in adults

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Gepirone is a serotonin receptor agonist used to treat major depressive disorder in adults

作用机制

The mechanism of the antidepressant effect of gepirone is not fully understood but is thought to be related to its modulation of serotonergic activity in the CNS through selective agonist activity at 5HT receptors. Particularly, gepirone

适应症

Gepirone is indicated for the treatment of major depressive disorder (MDD) in adults.

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Drug combination for the treatment of depression and related disorders comprising mirtazapine
US 2005090488 A1申请人: AKZO NOBEL NV优先权: 2000
US
3 件公开
3-HYDROXY GEPIRONE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER AND SEXUAL DYSFUNCTION
US 2009281111 A1申请人: FABRE KRAMER PHARMACEUTICALS I优先权: 2009
CN
US
2 件公开
Pharmaceutical formulation of gepirone for oral administration
US 2003152621 A1申请人: EGBERINK J G J优先权: 2001
US
2 件公开
Treatment of sexual disorders
US 7538116 B2申请人: GIBERTINI MICHAEL优先权: 2004
US
2 件公开
Methods for treating psychological disorders using bioactive metabolites of gepirone
US 6534507 B1申请人: FABRE KRAMER PHARMACEUTICALS I优先权: 2000
US
Oral extended release formulation of gepirone
CN 1479620 A申请人: AKZO NOBEL NV优先权: 2000
CN
Use of bioactive metabolites of gepirone for the treatment of psychological disorders
US 2003220346 A1申请人: KRAMER STEPHEN J优先权: 2003
US
High-dosage extended-release formulation of gepirone
US 2006099267 A1申请人: FABRE KRAMER PHARMACEUTICALS I优先权: 2004
US
GEPIRONE-ER TREATMENT OF MAJOR DEPRESSION IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)
US 2013150375 A1申请人: FABRE KRAMER PHARMACEUTICALS INC优先权: 2012
US

药物

Gepirone

概览

作用机制

适应症

相关疾病

专利